John Lollar MD
- Department of Pediatrics
Professor
- (404) 727-5569
- jlollar@emory.edu
-
Aflac Cancer and Blood Disorders Center
Pediatrics
2015 Uppergate Drive
Academic Appointment
- Hemophilia of Georgia Professor of Pediatrics, Emory University
Education
Degrees
- BS from Louisiana State University
- MD from St. Louis University
Research
Publications
-
The mechanistic basis for interprotomer deglycosylation of antibodies by corynebacterial IgG-specific endoglycosidases.
Nat Commun Volume: 16 Page(s): 6147
07/04/2025 Authors: Sastre DE; Bournazos S; Huliciak M; Grace BAC; Boder EJ; Du J; Sultana N; Azzam T; Brown TJ; Flowers MW -
Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production.
J Thromb Haemost Volume: 23 Page(s): 440 - 457
02/01/2025 Authors: York ES; Dratch BD; Ito J; Horwitz SM; Emamian S; Ambarian JA; Gill S; Jones J; Chonat S; Lollar P -
Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A.
N Engl J Med Volume: 392 Page(s): 450 - 457
01/30/2025 Authors: Srivastava A; Abraham A; Aboobacker F; Singh G; Geevar T; Kulkarni U; Selvarajan S; Korula A; Dave RG; Shankar M -
Structural basis for inhibition of coagulation factor VIII reveals a shared antigenic hotspot on the C1 domain.
J Thromb Haemost Volume: 22 Page(s): 2449 - 2459
09/01/2024 Authors: Childers KC; Cowper B; Vaughan JD; McGill JR; Davulcu O; Lollar P; Doering CB; Coxon CH; Spiegel PC -
Nanobody activator improves sensitivity of the von Willebrand factor activity assay to multimer size.
J Thromb Haemost Volume: 22 Page(s): 2052 - 2058
07/01/2024 Authors: Liang Q; Parker ET; Dean G; Karpen MS; Wu Y; Wang X; Di Paola J; Maier CL; Meeks SL; Lollar P -
Human gut microbes express functionally distinct endoglycosidases to metabolize the same N-glycan substrate.
Nat Commun Volume: 15 Page(s): 5123
06/15/2024 Authors: Sastre DE; Sultana N; V A S Navarro M; Huliciak M; Du J; Cifuente JO; Flowers M; Liu X; Lollar P; Trastoy B -
Conformational activation and inhibition of von Willebrand factor by targeting its autoinhibitory module.
Blood Volume: 143 Page(s): 1992 - 2004
05/09/2024 Authors: Arce NA; Markham-Lee Z; Liang Q; Najmudin S; Legan ER; Dean G; Su AJ; Wilson MS; Sidonio RF; Lollar P -
Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor.
Blood Volume: 142 Page(s): 197 - 201
07/13/2023 Authors: Childers KC; Avery NG; Estrada Alamo KA; Davulcu O; Haynes RM; Lollar P; Doering CB; Coxon CH; Spiegel PC -
pH-dependent conformation of multimeric von Willebrand factor.
Blood Adv Volume: 7 Page(s): 2554 - 2557
06/13/2023 Authors: Smith IW; Parker ET; Lollar P -
Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody.
Nat Commun Volume: 14 Page(s): 2853
05/18/2023 Authors: Gupta A; Kao KS; Yamin R; Oren DA; Goldgur Y; Du J; Lollar P; Sundberg EJ; Ravetch JV